Archive for Marc Lichtenfeld
Senior Analyst, Mt. Vernon Research
Marc Lichtenfeld is Senior Analyst at Mt. Vernon Research. He's the group's healthcare and biotechnology specialist, writing frequently in the Xcelerated Profits Report and Smart Profits Report.
He's also the Director of Research of Access, an institutional-style research service, dedicated to finding the most explosive small-cap healthcare and biotech stocks.
Marc started his career as a trader at Carlin Equities, where he obtained his NASD license, before moving to the contrarian Avalon Research Group, where he worked with two of the greatest contrarians in recent decades. He then managed the Real Wealth portfolio at Weiss Research, where his buy recommendations beat the S&P 500 return by 17% over a six-month period. Marc also served as Senior Columnist at TheStreet.com, breaking several major stories on biotech companies.
Following are Marc Lichtenfeld’s investment newsletters and trading services:
- Co-Editor, Xcelerated Profits Report
- Editor, Access Research Group
« Previous Entries
How To Grab Growth And Solid Income From The Small-Cap Sector
Thursday, August 13th, 2009
by Marc Lichtenfeld
Why You Shouldn’t Chase The Current Stock Market Rally
Thursday, August 6th, 2009
by Marc Lichtenfeld
How To Turn Uncommon Knowledge Into Power And Profit
Thursday, July 30th, 2009
by Marc Lichtenfeld
A Trio Of Twisted Numbers… And How To Get Beyond The Fluff
Thursday, July 23rd, 2009
by Marc Lichtenfeld
Ignore The Hair-Brained Media: Four Tips To Combat The Limp Economy
Thursday, July 16th, 2009
by Marc Lichtenfeld
How The Michael Jackson Story Impacts Investors
Thursday, July 9th, 2009
by Marc Lichtenfeld
Home Ownership: Do You Have The Courage To Buy Into This Housing Market?
Thursday, July 2nd, 2009
by Marc Lichtenfeld
Avoiding Madoff-Ponzi Schemes: 3 Tips To Beat Investment Meltdowns
Thursday, June 25th, 2009
by Marc Lichtenfeld
What Obama’s Financial Reform Proposals Mean For You
Friday, June 19th, 2009
by Marc Lichtenfeld
Four More Ways To Profit From U.S. Healthcare Reform
Thursday, June 18th, 2009
by Marc Lichtenfeld
« Previous Entries
The Breakthrough You Won't Hear about from the Mainstream Media
While one of the world's deadliest diseases claims another 12 million people this year, one tiny company is fighting the surge with its revolutionary new technology. And get this - in a recent clinical trial, all patients treated with the technology showed a positive response within days.
An event this shocking should hit front page news all over the world, but right now only a handful of people are talking about it...
This could be the early-in opportunity most investors can only dream about. Read the full story for all the details.
|
